Unak Perihan, Cetinkaya Berkan
Department of Nuclear Applications, Institute of Nuclear Sciences, Ege University, Bornova, Izmir 35100, Turkey.
Appl Radiat Isot. 2005 Jun;62(6):861-9. doi: 10.1016/j.apradiso.2004.07.013.
Microdosimetric calculations of 131I have been evaluated for a single cell and for cell clusters. A VsBasic program has been used to calculate stopping power, linear energy transfer, range values and deposited energies per decay for beta particles, Auger and conversion electrons of 131I. The chemical composition of the cell has been taken into account in this model; results were compared with water medium. Besides, total absorbed doses have been calculated for the radionuclides distributed randomly within the cell and clusters. Cross-fire irradiation has been considered for clusters of cells. In this case, absorbed doses per cell within a cluster were found to be significantly higher than absorbed doses per single cell, depending on the cluster size. Results showed that 131I is a promising radionuclide for therapy of tumors from millimeter to centimeter dimensions.
已对单个细胞和细胞簇进行了¹³¹I的微剂量学计算。使用了一个Visual Basic程序来计算¹³¹I的β粒子、俄歇电子和转换电子的阻止本领、线能量转移、射程值以及每次衰变沉积的能量。该模型考虑了细胞的化学成分;并将结果与水介质进行了比较。此外,还计算了随机分布在细胞和细胞簇内的放射性核素的总吸收剂量。对于细胞簇考虑了交叉照射。在这种情况下,发现细胞簇内每个细胞的吸收剂量明显高于单个细胞的吸收剂量,这取决于细胞簇的大小。结果表明,¹³¹I是治疗毫米至厘米大小肿瘤的一种有前景的放射性核素。